ES Cell International & regenerative medicine.

Alan Colman; Doug Alliston

doi:10.2217/17460751.1.2.287

ES Cell International & regenerative medicine.

Alan Colman
, Doug Alliston

ES Cell International

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

1 Citation (Scopus)

Abstract

ES Cell International believes that human embryonic stem cells offer a renewable source material for the elaboration of a multitude of different tissues for use in human cell replacement therapy. There are many challenges to the successful implementation of this vision including technical, regulatory, financial and ethical hurdles. However with demographic changes towards an aging population in the richer countries, leading to growing demands of ways to combat degenerative disease, science would be remiss not to explore every potential medical solution.

Original language	English
Pages (from-to)	287-291
Number of pages	5
Journal	Regenerative Medicine
Volume	1
Issue number	2
DOIs	https://doi.org/10.2217/17460751.1.2.287
Publication status	Published - Mar 2006
Externally published	Yes

Access to Document

10.2217/17460751.1.2.287

Cite this

@article{a7dfde1b18b74b80bdbdce975b94ebb0,

title = "ES Cell International \& regenerative medicine.",

abstract = "ES Cell International believes that human embryonic stem cells offer a renewable source material for the elaboration of a multitude of different tissues for use in human cell replacement therapy. There are many challenges to the successful implementation of this vision including technical, regulatory, financial and ethical hurdles. However with demographic changes towards an aging population in the richer countries, leading to growing demands of ways to combat degenerative disease, science would be remiss not to explore every potential medical solution.",

author = "Alan Colman and Doug Alliston",

year = "2006",

month = mar,

doi = "10.2217/17460751.1.2.287",

language = "English",

volume = "1",

pages = "287--291",

journal = "Regenerative Medicine",

issn = "1746-0751",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - ES Cell International & regenerative medicine.

AU - Colman, Alan

AU - Alliston, Doug

PY - 2006/3

Y1 - 2006/3

N2 - ES Cell International believes that human embryonic stem cells offer a renewable source material for the elaboration of a multitude of different tissues for use in human cell replacement therapy. There are many challenges to the successful implementation of this vision including technical, regulatory, financial and ethical hurdles. However with demographic changes towards an aging population in the richer countries, leading to growing demands of ways to combat degenerative disease, science would be remiss not to explore every potential medical solution.

AB - ES Cell International believes that human embryonic stem cells offer a renewable source material for the elaboration of a multitude of different tissues for use in human cell replacement therapy. There are many challenges to the successful implementation of this vision including technical, regulatory, financial and ethical hurdles. However with demographic changes towards an aging population in the richer countries, leading to growing demands of ways to combat degenerative disease, science would be remiss not to explore every potential medical solution.

UR - https://www.scopus.com/pages/publications/34249730024

U2 - 10.2217/17460751.1.2.287

DO - 10.2217/17460751.1.2.287

M3 - Article

C2 - 17465812

AN - SCOPUS:34249730024

SN - 1746-0751

VL - 1

SP - 287

EP - 291

JO - Regenerative Medicine

JF - Regenerative Medicine

IS - 2

ER -

ES Cell International & regenerative medicine.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this